Article thumbnail

Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer

By Carolien K. M. Vermeulen, Workineh Tadesse, Maite Timmermans, Roy F. P. M. Kruitwagen and Tom Walsh
Topics: Cat02 SCI/SSCI journal (WI-1), Epithelial ovarian cancer, Cytoreductive surgery, Debulking surgery, Neoadjuvant chemotherapy, Survival, GRADE SEROUS CARCINOMA, PRIMARY SURGERY, INTERVAL DEBULKING, CYTOREDUCTIVE SURGERY, STAGE IV, METAANALYSIS, VALIDATION, PROGNOSIS, SURVIVAL, SYSTEM
Year: 2017
DOI identifier: 10.1016/j.ejogrb.2017.10.019
OAI identifier:
Provided by: NARCIS
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.loc.gov/mods/v3 (external link)
  • https://cris.maastrichtunivers... (external link)
  • https://cris.maastrichtunivers... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.